First, reduction in the number of infected cells is suggested by the present findings that EZH2 and EZH1/2 inhibitors reduced proviral load in PBMCs from patients with HAM (Figure 4E) and decreased the viability of HTLV-1-infected cells lines (Figure 5). Here, EZH2 is linked to tropical spastic paraparesis.